Spatial, Temporal and Numeric Analysis of Alzheimer Changes in the Nucleus Coeruleus

The distribution of neurofibrillary tangles in the nucleus coeruleus was topographically and quantitatively analyzed. The topographical analysis showed statistically significant differences with regard to the distribution of neurofibrillary tangles in the dorsal-ventral and medial-lateral axes. More neurofibrillary tangles were found to be located in the dorsal and medial regions than in ventral and lateral areas. No significant difference in neurofibrillary tangle content was found between the rostral and the caudal areas of the nucleus coeruleus. Neurofibrillary tangle formation begins in the central parts of the nucleus coeruleus. The total number of neuromelanized neurons in the nucleus coeruleus was determined using a modern, unbiased sampling scheme and related to the cortical stage of Alzheimer's disease-related neurofibrillary changes present. A statistically significant reduction (50%) in nucleus coeruleus neurons was evident only in cases meeting the histopathological criteria for Alzheimer's disease. The extent of reduction in the total number of neurons in the nucleus coeruleus did not correlate with the number of neurofibrillary tangles observed. Our data suggest that despite the relatively early susceptibility of the nucleus coeruleus to neurofibrillary tangle formation, significant neuronal loss appears to occur much later, with an estimated average delay time of at least 25 years. Nonetheless, comparison of the topographical pattern of neurofibrillary tangle formation and cell loss indicates that neuronal loss is tangle-related.

[1]  V. Chan‐Palay,et al.  Quantitation of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression , 1989, The Journal of comparative neurology.

[2]  F E Bloom,et al.  Histochemical characterization of a neocortical projection of the nucleus locus coeruleus in the squirrel monkey , 1975, The Journal of comparative neurology.

[3]  P. Yates,et al.  The topography of cell loss from locus caeruleus in Alzheimer's disease , 1986, Journal of the Neurological Sciences.

[4]  Wade K. Smith,et al.  Disease‐specific patterns of locus coeruleus cell loss , 1992, Annals of neurology.

[5]  M. Roth,et al.  Neurofibrillary degeneration and neuronal loss in alzheimer's disease , 1989, Neurobiology of Aging.

[6]  H. Gundersen,et al.  Unbiased stereological estimation of the number of neurons in the human hippocampus , 1990, The Journal of comparative neurology.

[7]  F. Gallyas,et al.  Silver staining of Alzheimer's neurofibrillary changes by means of physical development. , 1971, Acta morphologica Academiae Scientiarum Hungaricae.

[8]  V. Chan‐Palay,et al.  Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression , 1989, The Journal of comparative neurology.

[9]  C. Barnes,et al.  Immunohistochemical evidence for coexistence of methionine-enkephalin and tyrosine hydroxylase in neurons of the locus coeruleus complex projecting to the spinal cord of the cat , 1992, Journal of Chemical Neuroanatomy.

[10]  P. Yates,et al.  The noradrenergic system in Alzheimer and multi-infarct dementias. , 1982, Journal of neurology, neurosurgery, and psychiatry.

[11]  P. Yates,et al.  The pathology of the human locus ceruleus. , 1983, Clinical neuropathology.

[12]  J. R. Unnerstall,et al.  Identification of a subpopulation of neuropeptide Y‐containing locus coeruleus neurons that project to the entorhinal cortex , 1990, Synapse.

[13]  D. Mann,et al.  The topography of nerve cell loss from the locus caeruleus in elderly persons , 1989, Neurobiology of Aging.

[14]  F. Bloom,et al.  Efferent projections of nucleus locus coeruleus: Topographic organization of cells of origin demonstrated by three-dimensional reconstruction , 1986, Neuroscience.

[15]  D. Price,et al.  The neuropathology of aminergic nuclei in Alzheimer's disease , 1988, Progress in clinical and biological research.

[16]  B. Bogerts.  A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker , 1981, The Journal of comparative neurology.

[17]  E. Perry,et al.  Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease , 1981, Journal of the Neurological Sciences.

[18]  J. Olszewski,et al.  Cytoarchitecture of the Human Brain Stem , 1955 .

[19]  J. Bohl,et al.  Unbiased Estimation of Neuronal Numbers in the Human Nucleus Coeruleus during Aging , 1997, Neurobiology of Aging.

[20]  R. M. Bowker,et al.  Origins and terminations of descending noradrenergic projections to the spinal cord of monkey , 1984, Brain Research.

[21]  P. Yates,et al.  Changes in Alzheimer's disease in the magnocellular neurones of the supraoptic and paraventricular nuclei of the hypothalamus and their relationship to the noradrenergic deficit. , 1985, Clinical neuropathology.

[22]  U. Slager,et al.  Pathologic correlates of dementia in Parkinson's disease. , 1986, Archives of neurology.

[23]  P. Yates,et al.  A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[24]  H. Braak,et al.  Alzheimer's disease: Mismatch between amyloid plaques and neuritic plaques , 1989, Neuroscience Letters.

[25]  H. Braak,et al.  Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes , 1995, Neuroscience.

[26]  H. Braak,et al.  A competition between silver-stain and immunocytochemistry , 1989 .

[27]  P. Yates,et al.  A comparison of nerve cell loss in cortical and subcortical structures in Alzheimer's disease. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[28]  Wade K. Smith,et al.  The human locus coeruleus: computer reconstruction of cellular distribution , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  A. Graybiel,et al.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease , 1988, Nature.

[30]  W. Bondareff,et al.  Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia , 1982, Neurology.

[31]  W. Bondareff,et al.  Number of neurons in nucleus locus ceruleus in demented and non-demented patients: Rapid estimation and correlated parameters , 1986, Neurobiology of Aging.

[32]  G. Blessed,et al.  Cell loss in the locus coeruleus in senile dementia of Alzheimer type , 1981, Journal of the Neurological Sciences.

[33]  H. J. G. Gundersen,et al.  The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[34]  F. E. Bloom,et al.  Loss of pigmented dopamine-β-hydroxylase positive cells from locus coeruleus in senile dementia of alzheimer's type , 1983, Neuroscience Letters.

[35]  H. Braak,et al.  Silver impregnation of Alzheimer's neurofibrillary changes counterstained for basophilic material and lipofuscin pigment. , 1988, Stain technology.

[36]  P. Yates,et al.  ALZHEIMER'S PRESENILE DEMENTIA, SENILE DEMENTIA OF ALZHEIMER TYPE AND DOWN'S SYNDROME IN MIDDLE AGE FORM AN AGE RELATED CONTINUUM OF PATHOLOGICAL CHANGES , 1984, Neuropathology and applied neurobiology.